Your session is about to expire
← Back to Search
Study Summary
This trial will help determine whether early ileostomy closure (EIC) is safe and feasible for select rectal cancer patients undergoing restorative proctectomy (RP) with a diverting loop ileostomy (DLI) in North America.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I had surgery for rectal cancer that involved creating a temporary ileostomy.My health conditions score is above 6 on the Charlson index.I can speak and understand English or French and can give informed consent.My CT scan after surgery showed no leaks in my intestine.I had another major surgery at the same time as my main operation.I have not received immunosuppressive therapy within 6 weeks before surgery.I have had serious complications after my rectum surgery.I am 18 years old or older.
- Group 1: Early Ileostomy Closure
- Group 2: Traditional closure (control)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could I have the chance to be a volunteer in this clinical experiment?
"This research is looking for 118 individuals afflicted with rectal cancer of between 18 and 90 years old. Additionally, applicants must meet these prerequisites: undergoing a restorative proctectomy by either laparoscopic, robotic, transanal total mesorectal excision or open approach; being an adult aged over 18; passing the negative anastomotic "leak test" via CT scan using rectally administrated water-soluble contrast on postoperative days 7, 8 or 9."
Is this research effort currently accepting participants?
"On clinicaltrials.gov, this trial is stated to be actively recruiting patients since its inception on February 22nd 2022 and recent revision on August 22nd 2022."
Is the enrollment criterion for this clinical trial limited to individuals over 20 years old?
"This medical study is accepting adults that are older than 18 and younger than 90."
How many healthcare centers are currently conducting this experiment?
"There are currently 4 sites that are partaking in this experiment, being Vancouver, London and Montreal. To avoid excessive travel needs, it is suggested to choose the most proximal location if you decide to take part."
What is the upper limit of enrollees for this research project?
"This research requires 118 volunteers who fit the criteria to be enrolled. Potential participants can register at St. Paul's Hospital, Providence Health Care (Vancouver), and London Health Sciences Centre (London)."
Share this study with friends
Copy Link
Messenger